Vaccine-induced blood clots under more scrutiny as Canada reports first case
OTTAWA — Concerns about vaccine safety emerged again Tuesday, as Canada reported its first case of vaccine-induced blood clots linked to Oxford-AstraZeneca, and the United States put the brakes on the Johnson & Johnson vaccine following six reports of blood clots there.
Officials in both countries, however, continued to stress the vaccines are safe, and their benefits outweigh their risks, even as investigations into what is causing the clots continue.
The vaccine news is also dropping as the third wave of COVID-19 is exploding. Canada now has one of the highest rates of new cases in the world, and a record number of patients in critical care.
The Quebec health ministry and Public Health Agency of Canada reported the Canadian blood clot in separate statements Tuesday afternoon. The woman, whose age was not specified, received the AstraZeneca vaccine made at the Serum Institute of India, known by the brand name Covishield.

